Splenic marginal-zone lymphoma: a distinct clinical and pathological entity
- 1 February 2003
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 4 (2) , 95-103
- https://doi.org/10.1016/s1470-2045(03)00981-1
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Splenic Marginal Zone Lymphomas Appear to Originate from Different B Cell TypesThe American Journal of Pathology, 2002
- Treatment of Splenic Marginal Zone B-Cell Lymphoma: An Analysis of 81 PatientsClinical Lymphoma, 2002
- Marginal zone cell lymphoma-an update on recent advancesHistopathology, 2002
- Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutationHuman Pathology, 1998
- Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B Lymphocyte SubsetsBlood, 1998
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994
- Splenic Marginal Zone Cell LymphomaThe American Journal of Surgical Pathology, 1992
- Malignant lymphoma presenting with prominent splenomegalya clinicopathologic study with special reference to intermediate cell lymphomaCancer, 1985
- Non-hodgkin's lymphoma.A study of the evolution of the disease based upon 92 autopsied casesCancer, 1979
- Staging laparotomies in unselected previously untreated patients with non-Hodgkin's lymphomasCancer, 1973